The development of the chamber angle was studied in the eyes of heterozygous Pax6 lacZ/1 mutant mice (Nature 387 (1997) 406). Mutations in PAX6 cause aniridia, a condition that is frequently associated with glaucoma, a blinding disease that may be associated with chamber angle defects. Mesenchymal cells were seen in the chamber angle at P1-P5. In wild-type mice, these cells differentiated into typical trabecular meshwork (TM) cells next to Schlemm's canal. In Pax6 lacZ/1 mice, TM cells remained undifferentiated and Schlemm's canal was absent. From P1 to P4, staining for b-galactosidase and immunoreactivity for Pax6 were observed in chamber angle mesenchyme, but were absent later. Cultured murine TM cells expressed Pax6. The defects in chamber angle and TM differentiation were associated with a wide spectrum of other anterior eye defects, which included various degrees of iris hypoplasia and corneal haze, isolated iridocorneal adhesions and atypical coloboma, and a vascularized cornea in all adult animals. A third of the animals showed Peters' anomaly including corneal opacity and iridocorneal adhesions. The separation of the lens from the cornea was incomplete, and epithelial layers of lens and cornea were continuous. Pax6 activity is directly required for differentiation of the chamber angle. Variations in phenotype of Pax6 lacZ/1 mice appear not to involve direct dominant-negative or dose-dependent effects. q
Introduction
Pax6, a member of the paired box family of transcription factors, has been identified as a key regulator of eye development in both vertebrates and invertebrates (Gehring and Ikeo, 1999; Ashery-Padan and Gruss, 2001; Chow and Lang, 2001) . During early mouse eye development, expression of Pax6 has been shown in the presumptive lens ectoderm, lens placode, lens vesicle and optic vesicle (Walther and Gruss, 1991; Grindley et al., 1995) . At later stages, Pax6 is found in epithelia of conjunctiva, cornea, lens and ciliary body, and in the neural retina (Davis and Reed, 1996; Koroma et al., 1997; Nishina et al., 1999) . Homozygous Small eye (Sey) mice, which have mutations in the Pax6 gene (Hill et al., 1991) , lack eyes and nasal cavities, exhibit central nervous system defects, and die soon after birth (Hogan et al., 1986; Grindley et al., 1995) . Heterozygous Sey mice show a reduction in external eye size, a characteristic iris hypoplasia, and at later stages corneal opacification and cataracts (Hogan et al., 1988) . In humans, heterozygous mutations in PAX6 have been demonstrated in a number of patients with aniridia Jordan et al., 1992; Glaser et al., 1992) , a panocular disease that is associated with iris hypoplasia, corneal opacification, cataract and foveal dysplasia. Mutations in PAX6 have also been found in patients with Peters' anomaly, autosomal dominant keratitis and isolated foveal hypoplasia (Prosser and van Heyningen, 1998) .
About 50-75% of patients with aniridia develop glaucoma, a disease which is characterized by an intraocular pressure (IOP) that is too high for the health of the optic nerve head (Walton, 1997) . The increase in IOP in patients with aniridia occurs in preadolescent or early adult years (Nelson et al., 1984; Mintz-Hittner, 1996; Walton, 1997) . Glaucoma in aniridia is thought to be due to developmental abnormalities in the chamber angle that obstruct aqueous humor outflow to the trabecular meshwork (TM) and Schlemm's canal which drains aqueous humor to the episcleral vessels outside the eye. The exact nature of the developmental defects that cause glaucoma in aniridia are unclear. It has been discussed that the stump of the hypoplastic iris progressively obstructs those parts of the TM which are important for the filtration of aqueous humor (Grant and Walton, 1974) . In contrast, histopathological analyses of several case reports have provided evidence of abnormal TM differentiation and/or complete absence of Schlemm's canal in patients with aniridia (Collins, 1893; Bergmeister, 1904; Callahan, 1949; Duke-Elder, 1964; Margo, 1983) . Still, for most of these case reports, the genetic type of aniridia is not clear, and in most cases later stages of glaucoma have been examined in which secondary changes may have been present. Abnormalities in chamber angle development are usually associated with other developmental defects in those tissues of the anterior eye segment that derive from ocular mesenchyme. In addition to Pax6, a substantial number of transcription factors (Pitx2, Pitx3, Foxc1, Foxe3, Lmx1b, Maf) has been identified to play a role for the proper differentiation of anterior ocular mesenchyme (Gould and John, 2002) . To gain insight into the mechanisms that cause glaucoma in patients with aniridia, and to learn more about the specific role of Pax6 for the morphogenesis of the chamber angle and the differentiation of ocular mesenchyme, we have investigated in the present study the anterior eye segment phenotype of heterozygote Pax6 lacZ/1 deficient mice (St Onge et al., 1997) . We demonstrate that haploinsufficiency for Pax6 leads to marked defects in chamber angle differentiation that are associated with a wide spec- Fig. 1 . Chamber angle mesenchyme at P5. In wild-type mice (A,B), a loose mesenchymal network of cells is observed in the chamber angle (solid arrow). An anterior chamber (AC) is present between iris (Ir) and cornea (Co). Isolated vessels (open arrow) are seen in the sclera, but Schlemm's canal is absent. In Pax6 lacZ/1 animals (C,D), the root of the iris is in contact with the cornea. Between the outer aspect of iris/ciliary body, and cornea/sclera, a compact strand of closely aggregated cells is observed (solid arrow). Re, retina; CB, ciliary body. trum of other anterior eye segment abnormalities. In addition, we provide evidence that Pax6 is expressed in developing anterior eye mesenchyme in the chamber angle, indicating a direct critical role of Pax6 for the morphogenesis of TM and Schlemm's canal.
Results

Differentiation of the TM is impaired in Pax6
lacZ/1 mice During postnatal day 1 (P1) to P5, a network of cells was observed in the iridocorneal or chamber angle of wild-type animals (Fig. 1A, B) . The cells were connected with each other by thin cellular processes. Between the cells, structurally empty extracellular spaces were present (Fig. 1B) .
Several isolated vessels were seen in the anterior sclera, but no vascular structure was found to be localized close to the cellular network in the chamber angle. From P6 to P14, the cells in the chamber angle differentiated into elongated, flat cells that covered lamellae of collagenous fibers, thereby forming the typical structural elements of the TM ( Fig. 2A, C) . The lamellae were in direct contact with the inner wall of Schlemm's canal, which was first observed in its typical position between chamber angle tissue and the inner side of the sclera at P9-P10. In parallel to the differentiation of Schlemm's canal, prominent episcleral veins developed at the outer, limbal region of cornea and sclera ( Fig. 2A) . By P14, the definite structural characteristics of the adult mouse chamber angle had been formed.
In heterozygous Pax6 lacZ/1 mice at P1-P5, the anterior chamber was smaller than in wild-type animals, and the root of the developing iris was in contact with the inner side of the cornea. Between the outer aspect of iris/ciliary body and the inner aspect of cornea/sclera, a strand of closely aggregated cells was observed (Fig. 1C, D) , which appeared to correlate with the cellular network that was present in the chamber angle of wild-type littermates. In contrast to wildtype animals, the chamber angle cells of Pax6 lacZ/1 mice did not form obvious cellular processes and were not separated from each other by open extracellular spaces. From P6 to P14, the iris of Pax6 lacZ/1 mice elongated and the ciliary processes become more prominent, while no apparent structural changes were observed in the cells between iris/ciliary body and cornea/sclera (Fig. 2B) . By electron microscopy, the cells expressed prominent cisterns of rough endoplasmic reticulum and were embedded in a matrix of extracellular fibrils (Fig. 2D) . Neither typical TM lamellae nor Schlemm's canal were present in Pax6 lacZ/1 mice at P14 or any later age (Fig. 2B, D) .
To analyze, if lack of structural differentiation was associated with lack of expression of typical TM genes in Pax6 lacZ/1 animals, we examined the localization of myocilin by immunohistochemistry. Myocilin is expressed in the adult TM at high levels, but not in young and fetal eyes (Tomarev et al., 1998; Tamm et al., 1999a; Swiderski et al., 2000) . In both Pax6 lacZ/1 animals and wild-type littermates, staining for myocilin was found in the ciliary epithelium as previously described (Karali et al., 2000) . More intense staining was seen in the TM of wild-type animals, while the chamber angle mesenchyme of Pax6 lacZ/1 mice was entirely unstained (Fig. 3A, B) .
Pax6 promoter activity in neural crest-derived cells during chamber angle development
In Pax6 lacZ/1 mice, activity of b-galactosidase is under control of the endogenous Pax6 promoter and reflects Pax6 expression. As Pax6 lacZ/1 mice showed defects in TM differentiation and chamber angle formation, we were interested, if b-galactosidase could be detected in the cells of this region. Following a 24 h incubation of eyes at P1-P5, b-galactosidase staining was confined to epithelial cells of lens, iris, ciliary body and cornea, corroborating earlier findings on Pax6 expression in the mouse eye (Koroma et al., 1997; Kammandel et al., 1999) . In contrast, after a 48 h incubation, positive staining was also seen in the cellular strand between iris/ciliary body and cornea/sclera, indicating that Pax6 is expressed in cells which differentiate to the TM in Pax6 1/1 mice (Fig. 4A, B) . No positive staining was seen after a 48 h incubation of wild-type Pax6 1/1 eyes (Fig. 4C ). There is some evidence that TM cells take their origin from neural crest-derived cells that migrate to the eye during development. From P1 to P5 and after a 48 h incubation, positive staining for b-galactosidase was also seen in other ocular cell types of presumably neural crest origin such as the stromal cells of iris, ciliary body and cornea, and the cells of the corneal endothelium ( Fig. 5A , C). Positive staining of corneal stroma cells did not extend beyond the limbal region, and no staining was observed in the sclera (Fig. 5A ). At later stages, staining of neural crest-derived cells became weaker. At P14, positive staining for b-galactosidase in the anterior eye was confined to epithelial cells of lens, iris and ciliary body, and to epithelial cells of the cornea at the limbus (Fig. 5B) . Eyes of wild-type Pax6 1/1 littermates were always negative when incubated for b-galactosidase staining (Fig. 5D ).
Pax6 expression is downregulated upon differentiation of TM cells
As b-galactosidase activity had been observed in chamber angle cells during early postnatal development, but not in adult eyes, we hypothesized that Pax6 expression is lacZ/1 animals (B) at P21. In both Pax6 lacZ/1 animals and wild-type littermates, staining for myocilin is found in the ciliary epithelium (CB). More intense staining is seen in the trabecular meshwork of wild-type animals (arrows), while the chamber angle mesenchyme of Pax6 lacZ/1 mice is entirely unstained. AC, anterior chamber; Co, cornea.
downregulated when neural crest-derived cells differentiate to TM cells. To test this hypothesis, we analyzed Pax6 expression in wild-type littermates at E19-P4 and P21 by immunohistochemistry. Positive staining was seen in epithelial cells of cornea, lens, iris, and ciliary body as previously described (Koroma et al., 1997) . In addition, positive staining was seen in mesenchymal cells of the chamber angle from E19 to P4, but not in the differentiated TM at P21 (Fig. 6A, B ). We then analyzed Pax6 expression in early passages of the murine TM cell line MUTM-NEI/1. MUTM-NEI/1 is a clonal and differentiated murine TM cell line that is derived from the H-2K b -tsA58 transgenic mouse strain in which promoter sequences of the major histocompatibility H-2K b class 1 gene are fused to the SV40 mutant temperature-sensitive (ts) strain tsA58 (Jat et al., 1991; Tamm et al., 1999b) . The promoter is inducible by interferon (IFN)-g, and the tsA58 gene product is active at 338C (permissive conditions), but not at 378C (non-permissive conditions). At non-permissive conditions, MUTM-NEI/1 cells differentiate and express typical TM genes (Tamm et al., 1999b) . By reverse transcriptase polymerase chain reaction (RT-PCR), products corresponding to transcripts of Pax6 and Pax6(5a) which result from alternative splicing, were amplified from RNA of MUTM-NEI/1 cells (Fig. 7A ). The intensity of both bands became weaker when RNA from later passages (.50) of MUTM-NEI/1 cells was used. Stronger bands of similar molecular weight were obtained from equal amounts of RNA isolated from the murine lens epithelial cells line a-TN4-1. Western blotting of nuclear proteins with specific antibodies against Pax6 showed a positive band with the molecular weight of Pax6 in MUTM-NEI/1 cells grown at 338C (permissive conditions), but not at 378C (non-permissive conditions) (Fig. 7B) . The band co-migrated with a band of similar molecular weight when nuclear proteins of the murine lens epithelial cells line a-TN4-1 were labeled. Labeling was more intense in equal amounts of nuclear proteins from a-TN4-1 cells than from MUTM-NEI/1 cells. Overall the results were consistent with the hypothesis that Pax6 is expressed in non-differentiated TM cells and is downregulated upon differentiation.
Chamber angle defects in Pax6
lacZ/1 mice are associated with a wide spectrum of additional anterior eye segment abnormalities While similar abnormalities in chamber angle structure were observed in all Pax6 lacZ/1 animals studied, other tissues of the anterior chamber showed defects that varied considerably between individual animals. In about one-third of Pax6 lacZ/1 mice, the cornea was found to be completely opaque immediately after eye opening (Fig. 8A) . The eyes of these animals were about 30-40% smaller than that of normal littermates. Upon serial step sectioning of the opaque transgenic cornea, a hole was found in the central corneal stroma (Fig. 8B) . The walls of the hole were covered by a layer of corneal epithelial cells that was continuous with the corneal epithelium on the outer side of the cornea. This layer of corneal epithelial cells was seen to penetrate through the hole in the corneal stroma and through an opposite hole in the lens capsule, and to merge with the anterior lens epithelium (Fig. 8C) . Before becoming continuous with the lens epithelium, corneal epithelial cells often formed a pocket that covered for some distance in both the inner side of the cornea and the anterior surface of the lens capsule (Figs. 8C and 9A) . In other places, the transition from lens to corneal epithelium was more direct, and the lens capsule merged in a straight line with the basal lamina of the corneal epithelium (Fig. 9C) . Next to the region of transition between lens and corneal epithelium, enlarged extracellular spaces were found between the lens fibers, which were filled with macrophages that had migrated through the anterior opening in the lens capsule (Figs. 8C and 9D ). In younger eyes with this phenotype that had not yet opened their eyes and that were between P0 and P14 of age, the hole in the central cornea was usually larger, and large homogenous masses of lens proteins were seen to leak out into the space between eyelid and cornea (Fig. 8D) . The apical surfaces of corneal epithelial cells on both sides of the cornea were characterized by numerous microvilli that were not observed on cells of the lens epithelium (Fig. 9A, B) . Where penetrating corneal epithelial cells covered the inner side of the cornea, corneal endothelium and Descemet's membrane were missing. In these regions, focal cell-matrix contacts were present at the basal side of the cells (Fig. 9E ). In addition, corneal epithelial cells were connected with each other by desmosomes (Fig. 9F ) which were not observed between cells of the corneal endothelium in control littermates. The corneal endothelium was also missing more laterally from the central defect in the cornea. In these areas, the anterior tip of the iris was directly attached to the inner side of the corneal stroma (Figs. 8B and 9F) . At the periphery of the cornea, the corneal endothelium was present and the iris was separated from the cornea.
In about 20% of Pax6 lacZ/1 mice, chamber angle defects were associated with relative minor additional anterior segment abnormalities. In these animals, the eyes were only about 10-15% smaller than that of wild-type littermates (Fig. 10A, B) . The cornea was transparent, with the exception of a discrete haze in the very center (Fig. 10B) . The iris was not attached to the cornea, but was shorter and left a larger pupillary opening after miotic treatment with pilocarpine than that of control animals (Fig. 10A, B) . In contrast to wild-type animals, the stroma was markedly thinner, the iris sphincter was hypoplastic and a collarette was not observed (Fig. 10A-D) .
In about 50% of Pax6 lacZ/1 mice, a more intermediate phenotype was observed. These animals often showed coloboma of the iris or segmental anterior synechia (Fig. 10E,  F) . The cornea of these animals showed opacities and in the central region abnormalities of the corneal epithelium ( Fig.  10E-H) . Some of the animals had a central anterior cleft in the cornea which did not completely penetrate through the corneal stroma. Others expressed a pannus-like accumulation of epithelial cells in the center of the cornea. At the inner aspect of the cornea, the endothelium was missing and the lens was often found to be in direct contact with the corneal stroma.
All Pax6 lacZ/1 mice investigated that were older than 4 weeks of age showed a vascularization of the cornea (Fig.  11) . 
Discussion
In the present study we have investigated, if the development of the iridocorneal or chamber angle is impaired in heterozygous Pax6 lacZ/1 deficient mice. We demonstrate that the tissue structures of the chamber angle, which form the major drainage pathway of aqueous humor do not differentiate. The TM remains in an immature state and is not in contact with any vascular structure comparable to Schlemm's canal in normal littermates. These findings agree with those observed in two children with aniridia and Wilm's tumor associated with a partial deletion of the short arm of chromosome 11 (Margo, 1983) where PAX6 is located (Ton et al., 1992; Jordan et al., 1992) . They also agree with several earlier histopathological case reports in which the genetic type of aniridia had not been determined (Collins, 1893; Bergmeister, 1904; Callahan, 1949; DukeElder, 1964) . It is reasonable to assume that the abnormal chamber angle development leads to an increase in resistance to aqueous humor outflow, which finally causes an increase in IOP and the development of glaucoma in patients with aniridia. At present, we do not know, if the chamber angle abnormalities in Pax6 lacZ/1 deficient mice do similarly affect IOP and induce glaucomatous optic nerve damage as they do in humans. Due to the small size of the mouse eye, the only method that is established so far to reliably measure IOP in mice involves invasive cannulation of the anterior chamber (John et al., 1997) . In our hands, this procedure was impossible to perform in Pax6 lacZ/1 mice, because of the presence of additional anterior segment abnormalities and the abnormal small size of the anterior chamber.
The TM belongs to those mesenchymal tissues in the anterior eye that do not derive from the neuroectoderm of the optic cup or the surface ectoderm. Fate mapping studies using quail-chick chimeras have shown an extensive cranial neural crest contribution to the formation of the TM as well as to the stroma of iris, ciliary body and cornea, and to the corneal endothelium (Johnston et al., 1979) . Cell grafting and cell labeling experiments of craniofacial morphogenesis in the mouse have confirmed the neural crest derivation, but have also provided evidence for the presence of additional cranial paraxial mesoderm-derived cells in the ocular mesenchyme (Trainor and Tam, 1995) . The importance of Pax6 for the morphogenesis of cranial neural crest-derived structures has been shown in Pax6 deficient small eye (Sey) rats. The migration of midbrain neural crest cells to craniofacial targets is impaired in seyR/ seyR embryos and causes considerable craniofacial defects (Matsuo et al., 1993; Nagase et al., 2001 ). In the eye, lack of Pax6 does not only interfere with the differentiation of the TM, but also with that of other neural crest-derived mesenchymal tissues, thereby contributing to iridial and corneal defects (Hogan et al., 1988) . It has been assumed that Pax6 acts indirectly on the differentiation of neural crest-derived eye tissues (Collinson et al., 2001) , as Pax6 expression has only been found in ocular cells that derive from the neuroectoderm of the optic cup or from the anterior surface ectoderm (Walther and Gruss, 1991; Grindley et al., 1995; Davis and Reed, 1996; Koroma et al., 1997; Nishina et al., 1999) . In addition, it has been reported that eye size and defects in iris and cornea are corrected in Pax6 1/1 $ Pax6 1/2 chimeric mice, in which lens epithelial cells are of Pax6 1/1 genotype, while the rest of the anterior eye is populated by up to 80% mutant Pax6 1/2 cells (Collinson et al., 2001) . A possible way by which Pax6 might indirectly act on neural crest-derived mesenchyme in the eye could be by modifying the secretion of lensderived signaling molecules. Indeed, the lens is known to profoundly influence the development of anterior eye mesenchyme (Genis-Galvez, 1966; Beebe and Coats, 2000) , and Pax6 is highly expressed in anterior lens epithelial cells (Walther and Gruss, 1991; Grindley et al., 1995; Davis and Reed, 1996; Koroma et al., 1997) .
Our results indicate that Pax6 acts also directly on chamber angle and TM development as Pax6 expression was observed by b-galactosidase staining in the developing chamber angle mesenchyme of heterozygous Pax6 lacZ/1 mice, and by immunostaining in wild-type littermates and cultured murine TM cells. The intensity of the staining was weaker than in cells of neuroepithelial origin and only observed during the short pre-and postnatal period of TM differentiation (Smith et al., 2001) , which might both be reasons why Pax6 expression in this region was not detected in earlier studies. We hypothesize that Pax6 is required during the early events of chamber angle differentiation, when neural crest-derived cells migrate to this region and proliferate, but is downregulated in fully differentiated, postmitotic TM cells (Fig. 12) . The hypothesis is supported by the finding that immunostaining for Pax6 could be detected in cultured murine TM cells under permissive, non-differentiated conditions, but not at non-permissive, differentiated conditions. This differentiation-dependent expression pattern of Pax6 in neural crest-derived mesenchyme is in parallel to recent findings on Pax6 expression during embryonic morphogenesis of the submandibular gland, where Pax6 expression was found in neural crestderived glandular mesenchyme during early and late initial bud stages, but not at later stages of glandular development (Jaskoll et al., 2002) . A differentiation-dependent expression of Pax6 has also been observed in ocular cells of surface ectoderm origin. In the embryonic lens, Pax6 is detectable in the nuclei of the postmitotic fiber cells after their generation by the proliferative zone, but it seems to be reduced as lens fiber cell differentiation proceeds (Richardson et al., 1995; Koroma et al., 1997; Duncan et al., 1998; Zhang et al., 2001 ). In addition, in the corneal epithelium of P14 mice, we observed Pax6 promoter activity in the limbus region where the stem cells of the epithelium are known to be located, but not in the less mitotically active and more differentiated epithelial cells in the central parts of the cornea. Interestingly, Pax6 is upregulated during the wound-healing response of the cornea, when corneal epithelial cells outside the limbus region become mitotically active and repair a deepithelializing injury of the cornea (Sivak et al., 2000) . The defects in chamber angle and TM differentiation in Pax6 lacZ/1 deficient mice were associated with a wide spectrum of other developmental defects in anterior eye morphogenesis. These defects included various degrees of iris hypoplasia and corneal haze, isolated iridocorneal adhesions and coloboma, and a vascularized cornea in all adult animals. About a third of the animals, however, showed a very distinct phenotype including an incomplete separation of the lens from the cornea, a central corneal opacity (leucoma) and iridocorneal adhesions (synechiae) extending from the central iris to the periphery of the corneal opacity. All these features characterize Peters' anomaly in humans (Schottenstein, 1996) , a condition which in some affected patients has been shown to be associated with mutations in PAX6 (Hanson et al., 1994) . Peters has originally postulated that this disorder is caused by an incomplete separation of the lens vesicle from the surface ectoderm and has suggested a primary ectodermal abnormality (Peters, 1906) . In support of this, stalk-like connections between lens and cornea have been observed in some case reports of human patients suffering from Peters' anomaly (Hamburg, 1967; Harden et al., 1970) . Our findings of a continuous epithelial cell layer that extends all the way from the surface of the cornea to the anterior surface of the lens in Pax6 lacZ/1 deficient mice clearly supports Peters' original hypothesis. The findings also corroborate earlier observations on a delay of lens placode formation and failure of complete lens detachment from the cornea in embryonic heterozygous Pax6 2/1 mice (Hogan et al., 1986; van Raamsdonk and Tilghman, 2000; Collinson et al., 2001) . Overall, the relative high percentage of Pax6 lacZ/1 deficient mice showing the phenotype of Peters' anomaly is surprising, since PAX6 mutations in humans with Peters' anomaly are only seldom observed (Churchill et al., 1998) and are usually associated with rare missense mutations in PAX6 (Hanson et al., 1994) . Missense mutations may reduce rather than eliminate Pax6 function and may cause different phenotypes as those observed in haploinsufficient individuals, since the dose of Pax6 has been shown to be a critical factor during eye development (Schedl et al., 1996; Duncan et al., 2000) . Experimental data also suggest that some missense and truncation mutations in Pax6 result in dominant-negative mutants, which may also lead to the differences in ocular phenotypes of individuals with PAX6 mutations (Tang et al., 1997; Singh et al., 1998 Singh et al., , 2000 Singh et al., , 2001 . It is extremely unlikely though that such dose-or dominant-negative effects are responsible for the wide spectrum of ocular phenotypes that we have observed in Pax6 lacZ/1 deficient mice in the present study. A possible explanation could be the action of modifying genes that Fig. 12 . Schematic drawing showing the proposed role of PAX6 for anterior eye development. A high and continuous expression of PAX6 in cells of ectodermal origin (lens, corneal epithelium, iris and ciliary epithelium) is important for the expression of regulatory and structural genes in these tissues, as well as for the expression of signaling molecules that act on cells of mesenchymal origin in the anterior eye (trabecular meshwork, stroma of iris, ciliary body and cornea). In addition, a low and transient expression of Pax6 is observed in cells of mesenchymal origin during development of the trabecular meshwork, chamber angle, iris and ciliary body. This expression is important for proper differentiation of trabecular meshwork and chamber angle. might critically influence Pax6 function in Pax6 lacZ/1 deficient mice, which have been maintained in an offbred NMRI-background. Whatever mechanism modifies the phenotype in Pax6 lacZ/1 deficient mice, it might well do so in humans with mutations in PAX6.
Experimental procedures
Light and electron microscopy
Eyes were obtained from Pax6 lacZ/1 mice (St Onge et al., 1997) and normal littermates every day between embryonic day (E) 19 to postnatal day (P) 14, and from animals at 3, 4, 5 and 6 weeks of age. The genotypes were determined by PCR analysis on DNA extracted from the tail. After enucleation, one eye from each animal was fixed for 24 h in 4% paraformaldehyde, washed extensively in phosphate buffered saline (PBS) and embedded in paraffin wax according to standard protocols. Paraffin (7 mm) sections were stained with hematoxylin and eosin. The fellow eye of each animal was placed in Ito's fixative (Ito and Karnovsky, 1968) for 24 h. While in fixative, the posterior hemisphere of eyeballs was pierced with a fine needle. After fixation, the eyes were washed overnight in cacodylate buffer, postfixed with OsO 4 , dehydrated, and embedded in Epon (Roth, Karlsruhe, Germany). One micrometer semithin sections were stained with toluidine blue. Ultrathin sections were stained with uranyl acetate and lead citrate, and viewed with a Zeiss (EM 902, Zeiss, Oberkochen, Germany) electron microscope. For immunofluorescence, antibodies against Pax6 (Eurogentec, Seraing, Belgium) were used at a dilution of 1:50, and antibodies against myocilin (Karali et al., 2000) at a dilution of 1:150 on paraffin sections. After overnight incubation, the sections were treated for 1 h with biotinylated secondary antibodies and finally with FITC streptavidin (Vector Laboratories, Burlingame, CA, USA) for 1 h each, and mounted in fluorescent mounting medium. For controls, sections were incubated with non-immunized rabbit serum instead of the primary antibodies.
To study pupillary size under contracted (miotic) or dilated (mydriatic) conditions, the animals were injected (i.p.) under deep anesthesia with pilocarpine or atropine, respectively. After 10 min, the eyes were enucleated and photographed.
Staining for b -galactosidase activity
Eyes were fixed in 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.3) at 48C for 1 h. After three 30 min rinses (in 0.01% sodium deoxycholate, 0.02% NP-40, 2 mM MgCl 2 and 0.1 M phosphate buffer, pH 7.3), b-gal activity was visualized in X-Gal staining solution (0.1 M phosphate buffer, pH 7.3, 3 mM MgCl 2 , 0.01% sodium deoxycholate, 0.02% NP-40, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 1 mg/ml X-Gal). The eyes were stained in X-Gal solution at 48C for 24 and 48 h, washed in PBS and embedded in paraffin.
RT-PCR and Western blotting
Pax6 and Pax6(5a) specific transcripts were amplified by RT-PCR using a primer pair across the paired domain, CAGAAGACTTTAACCAAGGGC and TGGGCTATT-TTGCTTACAACTT, generating specific products of 395 and 437 bp, respectively, using a One-step RT-PCR system (Invitrogen, Gaithersburg, MD, USA). The initial RT step was conducted at 428C for 30 min, followed by 35 cycles at annealing temperature of 548C. Control RNA were prepared from mouse lens epithelial cell line aTN4-1 expressing endogenous Pax6/Pax6(5a) . PCR products were verified by DNA sequencing.
The nuclear extracts prepared from proliferating and differentiating TM, and aTN4-1 cells were prepared as described elsewhere (Kirstein et al., 2000) , loaded onto a 4-15% gradient sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel (Bio-Rad, Hercules, CA, USA), and transferred to a nitrocellulose membrane. Pax6 specific monoclonal antibody (Developmental Studies Hybridoma Bank, Iowa City, IA, USA) was used at dilution 1:500; anti-mouse HRPO secondary antibody (Vector Laboratories) at dilution 1:5000, and the signals were detected by a Super Signal West Pico Luminol kit (Pierce, Rockford, IL, USA).
